Effectiveness and safety of apremilast in biologic‐naïve patients with moderate psoriasis treated in routine clinical practice in Greece: the APRAISAL study-Reference-Cited by-同舟云学术

Effectiveness and safety of apremilast in biologic‐naïve patients with moderate psoriasis treated in routine clinical practice in Greece: the APRAISAL study

Published:2021-07-13 Issue:9 Volume:35 Page:1838-1848
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Ioannides D.¹^ORCID,Antonakopoulos N.²,Georgiou S.³,Chasapi V.⁴,Katsantonis I.⁵,Drosos A.⁶,Rigopoulos D.⁷^ORCID,Antoniou C.⁷,Anastasiadis G.⁸,Bassukas I.⁹^ORCID,Ioannidou D.¹⁰,Protopapa A.¹¹,Neofotistou O.¹²,Krasagakis K.¹³,Aronis P.¹⁴,Papageorgiou M.¹⁵,Lazaridou E.¹⁶,Patsatsi A.¹⁶,Lefaki I.¹⁷,Roussaki‐Schulze A.V.¹⁸,Satra F.²,Anagnostopoulos Z.²^ORCID,Papakonstantis M.¹⁹

Affiliation:

1. 1^st University Department of Dermatology Aristotle University of Thessaloniki Hospital of Venereal & Skin Diseases of Thessaloniki Thessaloniki Greece

2. Genesis Pharma Athens Greece

3. Department of Dermatology University General Hospital of Patras Patras Greece

4. Dermatology and Venereology Department of N.H.S ‘Andreas Sygros’ Hospital Athens Athens Greece

5. Dermatology Unit Piraeus Regional General Hospital ‘Tzaneio’ Piraeus Greece

6. Department of Dermatology General Hospital of Xanthi Xanthi Greece

7. 1^st Department of Dermatology & Venereology National Kapodistrian University of Athens ‘Andreas Sygros’ Hospital Athens Greece

8. Department of Dermatology General Hospital of Athens ‘Evangelismos’ Athens Greece

9. Department of Skin and Venereal Diseases University of Ioannina Ioannina Greece

10. Department of Dermatology and Venereology General Hospital of Heraklion ‘Venizeleio‐ Pananeio’ Heraklion Greece

11. Outpatient Department of Dermatology General Hospital of Sitia Sitia Greece

12. Dermatology Department Konstantopoulio District General Hospital of Nea Ionia Athens Greece

13. Department of Dermatology University General Hospital of Heraklion Heraklion Greece

14. Clinical Dermatology Hellenic Airforce 251 General Hospital Athens Greece

15. State Department of Dermatology Hospital of Venereal & Skin Diseases of Thessaloniki Thessaloniki Greece

16. 2^nd University Department of Dermatology Aristotle University of Thessaloniki General Hospital of Thessaloniki ‘Papageorgiou’ Thessaloniki Greece

17. Dermatology Unit 'EUROMEDICA’ General Clinic Thessaloniki Greece

18. University Clinic of Dermatology University General Hospital of Larissa Larissa Greece

19. Clinic of Dermatology 401 General Military Hospital of Athens Athens Greece

Funder

Genesis Pharma

Celgene

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17392

Reference30 articles.

1. Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011

2. The negative impact of psoriasis on the workplace

3. The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE)

4. Efficacy and safety of apremilast in patients with moderate plaque psoriasis with lower BSA: week 16 results from the UNVEIL study;Strober B;J Drugs Dermatol,2017

5. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Is New in Nail Psoriasis?;Skin Appendage Disorders;2024-07-22

2. Efficacy of tyrosine-kinase-2 and phosphodiesterase-4 inhibitors for scalp psoriasis: a systematic review and meta-analysis;Current Medical Research and Opinion;2023-12-13

3. Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review;American Journal of Clinical Dermatology;2023-05-20

4. Apremilast Use in Severe Psoriasis: Real-World Data from Central and Eastern Europe;Advances in Therapy;2023-03-02

5. Apremilast and biologics: Characteristics of patients treated with apremilast before, during, or after a biological treatment;Dermatologic Therapy;2022-10-07